BOK Financial Corp: Form 10-Q for the period ended Mar 31, 2026
Filed with the SEC on May 6, 2026 and accepted by EDGAR at May 6, 2026, 16:05 ET.
Management's discussion and analysis
As filed, 1,423 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The following table provides information with respect to purchases made by or on behalf of the Company or any "affiliated purchaser" (as defined in Rule 10b-18(a)(3) under the Securities Exchange Act of 1934), of the Company's common stock during the three months ended March 31, 2026.
| Period | Total Number of Shares Purchased2 | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs1 | Maximum Number of Shares that May Yet Be Purchased Under the Plans |
|---|---|---|---|---|
| January 1 to January 31, 2026 | 30,343 | $123.57 | — | 2,017,039 |
| February 1 to February 28, 2026 | 41,080 | $133.80 | — | 2,017,039 |
| March 1 to March 31, 2026 | — | $— | — | 2,017,039 |
| Total | 71,423 | — |
1On July 29, 2025, the Company's Board authorized the Company to repurchase up to five million shares of the Company's common stock. As of March 31, 2026, the Company had repurchased 2,982,961 shares under this plan. Future repurchases of the Company's common stock will vary based on market conditions, regulatory limitations, and other factors.
2The Company may repurchase vested shares from employees to cover taxes in connection with employee equity compensation. During the three month period ended March 31, 2026, all share purchases were made in connection with employee equity compensation net tax settlements for vested equity awards.
Risk factors
As filed, 181 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There are no material changes from the risk factors set forth under Part I, Item 1A. "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2025.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2026-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Income tax | 3 months2026-01-01 to 2026-03-31 | $43.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2026-01-01 to 2026-03-31 | $155.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2026-01-01 to 2026-03-31 | $2.58 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2026-01-01 to 2026-03-31 | $2.58 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2026-01-01 to 2026-03-31 | 60,033,282 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2026-01-01 to 2026-03-31 | −$248.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2026-01-01 to 2026-03-31 | $35.7m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 3 months2026-01-01 to 2026-03-31 | $37.6m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months2026-01-01 to 2026-03-31 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Total assets | At period end2026-03-31 | $53.76bn | us-gaap:Assets |
| Total liabilities | At period end2026-03-31 | $47.79bn | us-gaap:Liabilities |
| Shareholders' equity | At period end2026-03-31 | $5.97bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2026-03-31 | 60,759,992 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000875357-26-000034. Last ingested by Listed: Oct 24, 2026, 14:58 ET. Listed shows no prices and gives no investment advice.